Table 1.
Quality assessment.
Study items | Siedner et al [24] (n=8) | Ownby et al [26] (n=6) | Robinson et al [27] (n=6) | Woods et al [25] (n=6) | Blackstock et al [28] (n=8) | Kim et al [29] (n=4) | Krishnan et al [30] (n=6) | |
Randomized controlled trial |
|
|
|
|
|
|
|
|
|
1. Was true randomization used for assignment of participants to treatment groups? | ✔ |
|
|
|
|
|
|
|
2. Was allocation to treatment groups concealed? |
|
|
|
|
|
|
|
|
3. Were treatment groups similar at the baseline? |
|
|
|
|
|
|
|
|
4. Were participants blind to treatment assignment? |
|
|
|
|
|
|
|
|
5. Were those delivering treatment blind to treatment assignment? |
|
|
|
|
|
|
|
|
6. Were outcomes assessors blind to treatment assignment? |
|
|
|
|
|
|
|
|
7. Were treatment groups treated identically other than the intervention of interest? | ✔ |
|
|
|
|
|
|
|
8. Was follow-up complete and, if not, were differences between groups in terms of their follow-up adequately described and analyzed? | ✔ |
|
|
|
|
|
|
|
9. Were participants analyzed in the groups to which they were randomized? | ✔ |
|
|
|
|
|
|
|
10. Were outcomes measured in the same way for treatment groups? | ✔ |
|
|
|
|
|
|
|
11. Were outcomes measured in a reliable way? | ✔ |
|
|
|
|
|
|
|
12. Was appropriate statistical analysis used? | ✔ |
|
|
|
|
|
|
|
13. Was the trial design appropriate, and any deviations from the standard randomized controlled trial design (individual randomization, parallel groups) accounted for in the conduct and analysis of the trial? | ✔ |
|
|
|
|
|
|
Quasi-experimental studies |
|
|
|
|
|
|
|
|
|
1. Is it clear in the study what is the “cause” and what is the “effect” (ie, there is no confusion about which variable comes first)? |
|
✔ | ✔ | ✔ |
|
|
|
|
2. Were the participants included in any comparisons similar? |
|
|
|
✔ |
|
|
|
|
3. Were the participants included in any comparisons receiving similar treatment or care, other than the exposure or intervention of interest? |
|
|
|
|
|
|
|
|
4. Was there a control group? |
|
|
|
✔ |
|
|
|
|
5. Were there multiple measurements of the outcome both pre and post the intervention or exposure? |
|
✔ | ✔ |
|
|
|
|
|
6. Was follow-up complete and, if not, were differences between groups in terms of their follow-up adequately described and analyzed? |
|
✔ | ✔ |
|
|
|
|
|
7. Were the outcomes of participants included in any comparisons measured in the same way? |
|
✔ | ✔ | ✔ |
|
|
|
|
8. Were outcomes measured in a reliable way? |
|
✔ | ✔ | ✔ |
|
|
|
|
9. Was appropriate statistical analysis used? |
|
✔ | ✔ | ✔ |
|
|
|
Cross-sectional studies |
|
|
|
|
|
|
|
|
|
1. Were the criteria for inclusion in the sample clearly defined? |
|
|
|
|
✔ | ✔ | ✔ |
|
2. Were the study subjects and the setting described in detail? |
|
|
|
|
✔ | ✔ | ✔ |
|
3. Was the exposure measured in a valid and reliable way? |
|
|
|
|
✔ |
|
✔ |
|
4. Were objective, standard criteria used for measurement of the condition? |
|
|
|
|
✔ |
|
✔ |
|
5. Were confounding factors identified? |
|
|
|
|
✔ | ✔ |
|
|
6. Were strategies to deal with confounding factors stated? |
|
|
|
|
✔ |
|
|
|
7. Were the outcomes measured in a valid and reliable way? |
|
|
|
|
✔ |
|
✔ |
|
8. Was appropriate statistical analysis used? |
|
|
|
|
✔ | ✔ | ✔ |